PZ-1922 freebase is a brain-penetrant 5-HT6R/5-HT3R antagonist (Ki = 17 nM and 0.45 nM, respectively); it reversibly inhibits MAO-B (pIC50: 8.93); it reverses scopolamine-induced memory deficits in the rat novel object recognition (NOR) test; it prevents Aβ-induced memory impairment in the T-maze test.